Výsledky vyhledávání - "Laura Turbino"

Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies

Autor: Rodolfo Montironi, Matteo Puntoni, Fabio Campodonico, Alessandra Argusti, Laura Turbino, Daniela Branchi, Andrea Decensi, Roberto Bandelloni, Marco Mori, Massimo Maffezzini, Silvia Zanardi

Publikováno v: Cancer Prevention Research. 2:377-384

Background: Men with elevated prostate-specific antigen (PSA) and negative prostate biopsies are at risk for prostate cancer. The antiandrogen bicalutamide has a prolonged half-life, thus potentially allowing an intermittent administration to retain

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6ea4ae18fc12068c54be582ad07d3a
https://doi.org/10.1158/1940-6207.capr-08-0205

Zobrazit plný text záznamu

A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma

Publikováno v: Cancer prevention research (Philadelphia, Pa.). 6(2)

Inflammation and oxidative stress play a crucial role in the development of colorectal cancer (CRC) and interference with these mechanisms represents a strategy in CRC chemoprevention. Allopurinol, a safe molecular scavenger largely used as antigout

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::922d770351d2f97a518be5c302f5da3f
https://pubmed.ncbi.nlm.nih.gov/23447561

Zobrazit plný text záznamu

Antioxidant supplement and long-term reduction of recurrent adenomas of the large bowel. A double-blind randomized trial

Autor: Paolo Bruzzi, Vincenzo Villanacci, Beatrice Gatteschi, Luigina Bonelli, Paolo Massa, Laura Turbino, Matteo Puntoni, Andrea De Censi, Francesco Munizzi, Guido Missale

Publikováno v: Journal of gastroenterology. 48(6)

Patients who undergo polypectomy are at increased risk of adenoma recurrence. The preventive potential of vitamins (A, C and E) and selenium supplementation represent an interesting opportunity for colorectal cancer prevention.To assess the efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0c3a19dfc27a711c092253f2fc1cec
https://pubmed.ncbi.nlm.nih.gov/23065023

Zobrazit plný text záznamu

Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7

Autor: Carlo Gelmetti, Clementina Cocuzza, Paolo Lusso, Francesco Drago, Laura Turbino, Alfredo Rebora, A Careddu, Chiara Foglieni, Francesco Broccolo, Mauro S. Malnati

Publikováno v: The Journal of investigative dermatology. 124(6)

To elucidate the role of human herpesvirus (HHV)-6 and -7 (HHV-7) in pityriasis rosea (PR), we measured their DNA load in plasma, peripheral blood mononuclear cells (PBMC), and tissues using a calibrated quantitative real-time PCR assay. We also stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c3c10780e5818b12d5de2110a24eb40
https://pubmed.ncbi.nlm.nih.gov/15955099

Zobrazit plný text záznamu

Abstract A68: Randomized presurgical trial of finasteride vs. flutamide vs. placebo in prostate cancer

Autor: Roberto Bandelloni, Rodolfo Montironi, Roberta Mazzucchelli, Alessandra Vagge, Andrea Decensi, Alfredo Santinelli, Laura Turbino, Marco Mori, Peter H. Bartels, Sara Campora, Rodolfo Hurle, Matteo Puntoni, Ottavio Decobelli, Giorgio Carmignani, Harriet Johansson, Massimo Maffezzini, Silvia Zanardi, Gabriella Rondanina

Publikováno v: Cancer Prevention Research. 3:A68-A68

Background: Prostate cancer (PC) is an ideal target for chemoprevention, with high-grade prostatic intraepithelial neoplasia (HGPIN) as its most likely precursor finasteride, a 5α-reductase inhibitor, reduced prostate cancer incidence by 25% in aver

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ebdedac94d111e3cdd08df50ef8fe42
https://doi.org/10.1158/1940-6207.prev-10-a68

Zobrazit plný text záznamu

Abstract A69: Randomized, presurgical study of allopurinol vs. placebo in subjects with colorectal adenomas

Autor: Cristiano Crosta, Laura Turbino, Matteo Puntoni, Egle Minetti, Roberto Bandelloni, Marco Mori, Sandra Salvi, Alessandra Argusti, Paolo Michetti, Daniela Branchi, Silvia Zanardi, Emanuele Meroni, Beatrice Gatteschi, Andrea Decensi, Gianni Coccia, Giuseppe De Roberto, Francesco Munizzi

Publikováno v: Cancer Prevention Research. 3:A69-A69

Rationale: Colorectal adenomas are well recognized colorectal cancer (CRC) risk markers, and regression of adenomas through chemopreventive strategies may reduce the incidence of CRC. Inflammation and oxidative stress appear to play a crucial role in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2933d6a16924ceb878bcb74737ab0db5
https://doi.org/10.1158/1940-6207.prev-10-a69

Zobrazit plný text záznamu

Abstract A80: Antioxidant supplement and long-term reduction of metachronous adenomas of the large bowel: Results of a double-blind randomized trial

Autor: Guido Missale, Matteo Puntoni, Luigina Bonelli, Beatrice Gatteschi, Laura Turbino, Paolo Massa, Vincenzo Villanacci, Andrea Decensi, Francesco Munizzi

Publikováno v: Cancer Prevention Research. 3:A80-A80

This is a double randomized trial aimed at evaluating the efficacy of antioxidants in reducing the incidence of metachronous adenomas (MA) of the large bowel after endoscopic polypectomy. A 50% reduction in the incidence of MA was expected in patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67a835a85cae6cfea9471123bd06b900
https://doi.org/10.1158/1940-6207.prev-09-a80

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání